July 19, 2023
4 min watch
Save
VIDEO: Treating anemia key for quality of life for patients with myelofibrosis
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Ruben Mesa, MD, discussed a study he presented at ASCO Annual Meeting examining the impact of transfusion burden on quality of life and functioning on patients with myelofibrosis.
Mesa, executive director of Atrium Health Wake Forest Baptist Comprehensive Cancer Center, highlighted the study, a post-hoc analysis of the SIMPLIFY-1 and SIMPLIFY-2 studies, which found that treating anemia had a very strong impact on patient energy and quality of life.
“This helped to answer the question that yes, by improving anemia, a difference was seen by that increase of oxygen-carrying capacity,” Mesa said.
Reference:
Mesa R, et al. Abstract 7066. Presented at: ASCO Annual Meeting; June 2-6, 2023; Chicago.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Mesa reports consulting for AbbVie, Blueprint Medicines, Bristol Myers Squibb, CTI BioPharma, Genentech, Geron, GSK, Incyte, MorphoSys, Novartis, Sierra Oncology and Telios Pharma.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.